CD8A and neoplasm: Consequently, our findings suggest that the heightened antitumor effects observed with the combination of DSP-0509 and anti-PD-1, in relation to individual agents, are mediated through the activation of CD8+ T cells rather than an increase in CD8+ T cell infiltration into the tumor.